Association between TSH levels and hepatic steatosis is mediated by metabolic syndrome factors (2017)
- Authors:
- Autor USP: BITTENCOURT, MÁRCIO SOMMER - HU
- Unidade: HU
- Subjects: FATORES DE RISCO; HORMÔNIOS TIREOIDIANOS; OBESIDADE
- Keywords: SÍNDROME METABÓLICA
- Language: Inglês
- Imprenta:
- Publisher: American Heart Association
- Publisher place: Dallas
- Date published: 2017
- Source:
- Título do periódico: Circulation
- ISSN: 0009-7322
- Volume/Número/Paginação/Ano: v. 136, suppl. 1, nov. 2014
- Conference titles: Resuscitation Science Symposium: Scientific Sessions 2017
-
ABNT
JANOVSKY, Carolina C et al. Association between TSH levels and hepatic steatosis is mediated by metabolic syndrome factors. Circulation. Dallas: American Heart Association. . Acesso em: 30 abr. 2024. , 2017 -
APA
Janovsky, C. C., Cesena, F. H., Tabone, V. A., Conceição, R. D., Santos, R. D., & Bittencourt, M. S. (2017). Association between TSH levels and hepatic steatosis is mediated by metabolic syndrome factors. Circulation. Dallas: American Heart Association. -
NLM
Janovsky CC, Cesena FH, Tabone VA, Conceição RD, Santos RD, Bittencourt MS. Association between TSH levels and hepatic steatosis is mediated by metabolic syndrome factors. Circulation. 2017 ; no 2014[citado 2024 abr. 30 ] -
Vancouver
Janovsky CC, Cesena FH, Tabone VA, Conceição RD, Santos RD, Bittencourt MS. Association between TSH levels and hepatic steatosis is mediated by metabolic syndrome factors. Circulation. 2017 ; no 2014[citado 2024 abr. 30 ] - Longitudinal changes in physical activity positively impact high sensitivity C-reactive protein levels
- Resting electrocardiographic variables of patients with severe coronary artery disease undergoing coronary artery bypass graft surgery plus intramyocardial bone marrow cell injection: an one-year follow up study
- Recurrent pulmonary edema caused by chronic left main coronary artery occlusion
- Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events
- Comparison of the use of downstream tests after exercise treadmill testing by cardiologists versus noncardiologists
- Eligibility for lipid lowering therapy based on AHA/ACC risk score, coronary artery calcification, and CVD events- national implications for the appropriate use of preventive pharmacotherapy: Multi-Ethnic Study of Atherosclerosis (MESA)
- Decreasing sample size in primary prevention studies: A potential role for coronary artery calcium score [letter]
- Prognostic value of coronary CTA vs. exercise treadmill testing: results from the Partners registry
- Yield of different approaches for screening for cardiovascular disease in asymptomatic diabetics
- Costs and diagnostic yield of exercise treadmill testing vs. exercise SPECT in symptomatic patients at intermediate risk of CAD
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas